IL86288A0 - Diastereomeric 5r,6s-6-(1r-hydroxyethyl)-2-(cis-1-oxo-3-thiolanylthio)-2-penem-3-carboxylic acids - Google Patents

Diastereomeric 5r,6s-6-(1r-hydroxyethyl)-2-(cis-1-oxo-3-thiolanylthio)-2-penem-3-carboxylic acids

Info

Publication number
IL86288A0
IL86288A0 IL86288A IL8628888A IL86288A0 IL 86288 A0 IL86288 A0 IL 86288A0 IL 86288 A IL86288 A IL 86288A IL 8628888 A IL8628888 A IL 8628888A IL 86288 A0 IL86288 A0 IL 86288A0
Authority
IL
Israel
Prior art keywords
thiolanylthio
penem
oxo
hydroxyethyl
diastereomeric
Prior art date
Application number
IL86288A
Other languages
English (en)
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Priority to IL10360988A priority Critical patent/IL103609A/en
Publication of IL86288A0 publication Critical patent/IL86288A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/86—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with only atoms other than nitrogen atoms directly attached in position 6 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/16—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by esterified hydroxyl radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/28—Halogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30—Hetero atoms other than halogen
    • C07D333/32—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30—Hetero atoms other than halogen
    • C07D333/34—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/46—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings substituted on the ring sulfur atom
    • C07D333/48—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings substituted on the ring sulfur atom by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/88—Compounds with a double bond between positions 2 and 3 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Epoxy Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Steroid Compounds (AREA)
IL86288A 1987-05-11 1988-05-05 Diastereomeric 5r,6s-6-(1r-hydroxyethyl)-2-(cis-1-oxo-3-thiolanylthio)-2-penem-3-carboxylic acids IL86288A0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IL10360988A IL103609A (en) 1987-05-11 1988-05-05 Intermediates for the preparation of diastereomeric 5r ls-6-(1r-hydroxyethyl)-2-(cis-1-oxo-3-thiolanylthio)-2-penem-3-carboxylic acids

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1987/001114 WO1988008845A1 (en) 1987-05-11 1987-05-11 Diastereomeric 5r,6s-6-(1r-hydroxyethyl)-2-(cis-1-oxo-3-thiolanylthio)-2-penem-3-carboxylic acids

Publications (1)

Publication Number Publication Date
IL86288A0 true IL86288A0 (en) 1988-11-15

Family

ID=22202388

Family Applications (1)

Application Number Title Priority Date Filing Date
IL86288A IL86288A0 (en) 1987-05-11 1988-05-05 Diastereomeric 5r,6s-6-(1r-hydroxyethyl)-2-(cis-1-oxo-3-thiolanylthio)-2-penem-3-carboxylic acids

Country Status (27)

Country Link
US (2) US5013729A (de)
EP (1) EP0294934B1 (de)
JP (2) JPH0737463B2 (de)
KR (1) KR900006840B1 (de)
CN (2) CN1023016C (de)
AT (1) ATE132869T1 (de)
AU (1) AU603665B2 (de)
CA (1) CA1338830C (de)
CS (1) CS269999B2 (de)
DD (1) DD270074A5 (de)
DE (1) DE3854874T2 (de)
DK (1) DK170443B1 (de)
EG (1) EG18481A (de)
ES (1) ES2081805T3 (de)
FI (1) FI96423C (de)
GR (1) GR3019094T3 (de)
IE (1) IE70587B1 (de)
IL (1) IL86288A0 (de)
MA (1) MA21265A1 (de)
MY (1) MY104306A (de)
NZ (1) NZ224552A (de)
PH (1) PH23931A (de)
PL (1) PL159558B1 (de)
PT (1) PT87443B (de)
WO (1) WO1988008845A1 (de)
YU (1) YU45059B (de)
ZA (1) ZA883291B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0352977A3 (de) * 1988-07-28 1991-08-07 Pfizer Inc. Stereoselektives Oxydierungsverfahren
EP0382418A3 (de) * 1989-02-09 1991-10-23 Pfizer Inc. Verfahren zur Herstellung von optisch aktiven 3-Thiolanylsulfonsäure-Estern
MX20084A (es) * 1989-03-28 1993-03-01 Pfizer Derivados de 2 -carbapenem antibacterianos
US5321020A (en) * 1989-03-28 1994-06-14 Pfizer Inc. Antibacterial 2-carbapenem derivatives
US5075439A (en) * 1990-08-17 1991-12-24 Pfizer Inc. Processes for (3S,4R)-3-[1(R)-t-butyl-dimethylsilyloxy)-ethyl]-4-[1-oxo-3-thiolanylthio(thiocarbonyl)thio]azetidin-2-ones and intermediates therefor
EP1712633A1 (de) * 2003-12-02 2006-10-18 Mercian Corporation Prozess zur herstellung von optisch aktivem tetrahydrothiophen-derivat und verfahren zur kristallisierung optisch aktiven tetrahydrothiophen-3-ols
JP2005314374A (ja) * 2004-03-31 2005-11-10 Daiso Co Ltd ３−ヒドロキシチオランの新規製法
KR100939347B1 (ko) 2005-07-20 2010-01-29 (주)카이로드 광학적으로 순수한 (ｓ)-3-히드록시 피롤리딘의 제조방법
PE20080940A1 (es) * 2006-06-28 2008-07-09 Pfizer Prod Inc Profarmacos de penem
CN101479279B (zh) * 2006-06-28 2011-08-17 辉瑞产品公司 培南前药
WO2008059367A1 (en) * 2006-11-14 2008-05-22 Pfizer Products Inc. Penem prodrugs
US20080125408A1 (en) * 2006-11-14 2008-05-29 Pfizer Inc Penem prodrug
EP2195443B1 (de) 2007-08-24 2015-01-07 Codexis, Inc. Verbesserte ketoreduktase-polypeptide zur stereoselektiven produktion von (r)-3-hydroxythiolan
CN105061394A (zh) * 2015-09-11 2015-11-18 北京工商大学 一种2-丙基-4-乙酰氧基四氢噻吩的制备方法
EP4382529A1 (de) 2022-12-07 2024-06-12 Bayer Consumer Care AG Verfahren zur herstellung von reinem (3s)-pyrrolidin-3-ol und reinem (3s)-pyrrolidin-3-ol-hydrochlorid

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0130025B1 (de) * 1983-06-21 1987-07-08 Pfizer Inc. 2-Alkylthiopenem-Derivate
US4619924A (en) * 1984-05-18 1986-10-28 Pfizer Inc. 2-alkylthiopenem derivatives
US4739047A (en) * 1985-10-17 1988-04-19 Pfizer Inc. Intermediates for 2-(1-oxo-3-thiolanyl)-2-penem antibiotics
ZA867809B (en) * 1985-10-17 1988-05-25 Pfizer Process for 2-(1-oxo-3-thiolanyl)-2-penem antibiotics
EP0223397B1 (de) * 1985-10-17 1991-09-04 Pfizer Inc. Verfahren für 2-(1-Oxo-3-thiolanyl)-2-penemantibiotika
US4806637A (en) * 1986-03-17 1989-02-21 Schering Corporation 6-(Hydroxyethyl)-2-(heterocyclylthio)-penem-3-carboxylates
US4695626A (en) * 1986-07-29 1987-09-22 Pfizer Inc. 1-aza-4,5-dithiabicyclo [4.2.0] oct-2-en-8-one-2 carboxylate esters
PH24872A (en) * 1986-08-25 1990-12-26 Schering Corp (5r,6s,8r)-6-(-1-hydroxyethyl)-2-(3r-pyrrolidin-2-one-3-yl)thiopenem-3-carboxylic acid

Also Published As

Publication number Publication date
AU1589688A (en) 1988-11-17
IE70587B1 (en) 1996-12-11
ES2081805T3 (es) 1996-03-16
JPH0737463B2 (ja) 1995-04-26
ATE132869T1 (de) 1996-01-15
DK170443B1 (da) 1995-09-04
CS269999B2 (en) 1990-05-14
NZ224552A (en) 1989-10-27
EP0294934A3 (en) 1989-01-25
EP0294934B1 (de) 1996-01-10
FI96423B (fi) 1996-03-15
JPS63287781A (ja) 1988-11-24
MA21265A1 (fr) 1988-12-31
MY104306A (en) 1994-03-31
YU45059B (en) 1991-06-30
PL159558B1 (pl) 1992-12-31
IE881411L (en) 1988-11-11
PT87443A (pt) 1989-05-31
DK255888A (da) 1989-02-07
DK255888D0 (da) 1988-05-10
JPH07278137A (ja) 1995-10-24
ZA883291B (en) 1989-12-27
KR880013943A (ko) 1988-12-22
PL272358A1 (en) 1989-10-30
CA1338830C (en) 1997-01-07
AU603665B2 (en) 1990-11-22
GR3019094T3 (en) 1996-05-31
US5319103A (en) 1994-06-07
PH23931A (en) 1990-01-23
DD270074A5 (de) 1989-07-19
KR900006840B1 (ko) 1990-09-22
CN1036996C (zh) 1998-01-14
DE3854874D1 (de) 1996-02-22
EG18481A (en) 1993-06-30
EP0294934A2 (de) 1988-12-14
YU90688A (en) 1989-12-31
CS311988A2 (en) 1989-08-14
PT87443B (pt) 1992-08-31
US5013729A (en) 1991-05-07
WO1988008845A1 (en) 1988-11-17
JP2544902B2 (ja) 1996-10-16
FI96423C (fi) 1996-06-25
CN1073442A (zh) 1993-06-23
CN88102863A (zh) 1988-12-21
CN1023016C (zh) 1993-12-08
DE3854874T2 (de) 1996-05-23
FI895369A0 (fi) 1989-11-10

Similar Documents

Publication Publication Date Title
GR3019094T3 (en) Diastereomeric 5R,6S-6-(1R-hydroxyethyl)-2-(cis-1-oxo-3-thiolanylthio)-2-penem-3-carboxylic acids
AU2206188A (en) Azithromycin and derivatives as antiprotozoal agents
KR0145958B1 (en) Antibacterial agents
DK0490823T3 (de)
GR3006674T3 (de)
DE3461467D1 (en) 6-(aminomethyl)penicillanic acid 1,1-dioxide esters and intermediates therefor
AU575067B2 (en) Salts of l or (s)-3-(3,4-dihydroxyphenyl)-2- methylalanine esters
EP0090603A3 (de) Bakterienhemmende Verbindungen
KR880022566U (ko) Vtr의 고속 역 재생기 주행 안정장치
YU39339B (en) Process for obtaining the pure proteolytic enzyme cathepsin d from various animal organs
IT1177962B (it) Composti 1,2,4-triazolici,procedimento per produrli e composizioni farmaceutiche che li contengono
IL103609A0 (en) Intermediates for the preparation of diastereomeric 5r,6s-6-(1r-hydroxyethyl)-2-(cis-1-oxo-3-thiolanylthio)-2-penem-3-carboxylic acids
IT8720114A0 (it) Procedimento migliorato per la purificazione di l-carnitinato di l-carnitina.